Diagnos, Inc. (ADK.V)
0.37
-0.02
(-3.90%)
CAD |
TSXV |
Oct 23, 16:00
Diagnos Profit Margin (Quarterly) : -7.54K% for March 31, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -7.54K% |
| December 31, 2025 | -7.64K% |
| September 30, 2025 | -7.21K% |
| June 30, 2025 | -5.74K% |
| March 31, 2025 | -7.27K% |
| December 31, 2024 | -4.67K% |
| September 30, 2024 | -4.49K% |
| June 30, 2024 | -1.95K% |
| March 31, 2024 | -1.93K% |
| December 31, 2023 | -1.55K% |
| September 30, 2023 | -2.29K% |
| June 30, 2023 | -1.74K% |
| March 31, 2023 | -1.07K% |
| December 31, 2022 | -421.7% |
| September 30, 2022 | -355.4% |
| June 30, 2022 | -481.3% |
| March 31, 2022 | -476.9% |
| December 31, 2021 | -466.2% |
| September 30, 2021 | -689.4% |
| June 30, 2021 | -947.4% |
| March 31, 2021 | -1.02K% |
| December 31, 2020 | -735.3% |
| September 30, 2020 | -441.4% |
| June 30, 2020 | -1.04K% |
| March 31, 2020 | -1.63K% |
| Date | Value |
|---|---|
| December 31, 2019 | -627.8% |
| September 30, 2019 | -665.7% |
| June 30, 2019 | -1.24K% |
| March 31, 2019 | -820.5% |
| December 31, 2018 | -1.09K% |
| September 30, 2018 | -2.31K% |
| June 30, 2018 | -1.03K% |
| March 31, 2018 | -1.56K% |
| December 31, 2017 | -58.08% |
| September 30, 2017 | -309.8% |
| June 30, 2017 | -6.95K% |
| March 31, 2017 | -399.8% |
| December 31, 2016 | 4.78% |
| September 30, 2016 | -1.53K% |
| June 30, 2016 | -572.1% |
| March 31, 2016 | -999.2% |
| December 31, 2015 | -196.8% |
| September 30, 2015 | -437.5% |
| June 30, 2015 | -464.6% |
| March 31, 2015 | -536.7% |
| December 31, 2014 | -321.8% |
| September 30, 2014 | -677.6% |
| June 30, 2014 | -611.1% |
| March 31, 2014 | -370.4% |
| December 31, 2013 | -97.37% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Evokai Creative Labs, Inc. | -- |
| Arch Biopartners, Inc. | -- |
| Avricore Health, Inc. | -354.9% |
| Kane Biotech, Inc. | -10.29K% |
| CardioComm Solutions, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -29.66K% |
| Return on Assets | -173.1% |
| Return on Invested Capital | -201.2% |
| Gross Profit Margin (Quarterly) | -2.24K% |
| Operating Margin (Quarterly) | -7.27K% |
| Return on Net Operating Assets | -1.57K% |